To access this content, you must be a member. Visit the Plans page for details.
Brahman, Viking, Coatue, Jana sell Valeant while Okumus, Farallon, Appaloosa buy in Q1
13F filings released today show that a number of hedge fund managers exited Valeant Pharmaceuticals in Q1. Because 13F [Read More]